Cellyan Biotechnology (HKPD) shares were down 21% in Friday premarket trading after the company said Nasdaq granted it an additional 180-day grace period to regain compliance with the exchange's minimum bid price requirement.
Eva Live (GOAI) stock was down 18%, extending the earlier session's 3.6% decline.
Regenxbio (RGNX) shares were down 17% after the company priced an underwritten public offering of common shares and pre-funded warrants.
Research Frontiers (REFR) stock was down 17%, adding to Thursday's 3.9% loss.
Cycurion (CYCU) shares were down 15% after the company said it received a Nasdaq delisting determination letter.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.